Tearsheet

ASP Isotopes (ASPI)


Market Price (11/18/2025): $7.3 | Market Cap: $533.0 Mil
Sector: Materials | Industry: Commodity Chemicals

ASP Isotopes (ASPI)


Market Price (11/18/2025): $7.3
Market Cap: $533.0 Mil
Sector: Materials
Industry: Commodity Chemicals

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 100%
  Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -33 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -720%
1 Megatrend and thematic drivers
Megatrends include Precision Medicine, and Advanced Materials. Themes include Nuclear Medicine, Specialty Chemicals for Performance, Show more.
  Expensive valuation multiples
P/SPrice/Sales ratio is 115x
2   Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -429%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -683%
3   Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 59%
4   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -23%
5   High stock price volatility
Vol 12M is 118%
6   Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 24%
7   Short seller report
Fuzzy Panda Research report on 11/26/2024.
0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 100%
1 Megatrend and thematic drivers
Megatrends include Precision Medicine, and Advanced Materials. Themes include Nuclear Medicine, Specialty Chemicals for Performance, Show more.
2 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -33 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -720%
3 Expensive valuation multiples
P/SPrice/Sales ratio is 115x
4 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -429%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -683%
5 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 59%
6 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -23%
7 High stock price volatility
Vol 12M is 118%
8 Significant short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 24%
9 Short seller report
Fuzzy Panda Research report on 11/26/2024.

Market Valuation & Key Metrics

ASPI Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

The search results indicate that today's date is indeed November 18, 2025, and there is news available for ASP Isotopes (ASPI) within the specified timeframe (July 31, 2025, to November 18, 2025). This means I can proceed with the request. Looking at the search results, several articles mention ASPI's stock performance and relevant news during this period. I need to synthesize this information to explain a -20.2% stock movement. Here's a breakdown of potentially relevant information from the search results: * **ASPI Stock Price and Performance:** * ASPI reached its all-time high on Oct 13, 2025, with the price of $14.49 USD. * On November 14, 2025, the price was $8.11. * On November 10, 2025, ASPI stock opened at $8.92. * The stock has a 50-day moving average of $9.65 and a 200-day moving average of $8.69 as of November 11, 2025. * The month change as of November 18, 2025, is a -38.93% fall. This is close to the -20.2% specified, but the timeframe is slightly different ("month change" vs. "7/31/2025 to today"). I need to calculate the actual change for the specified period. * According to one forecast (last updated Sep 17, 2025), the stock has a target of $11, predicting a 35.64% increase from the current stock price of $8. * StockScan shows a generally negative forecast for the next 30 days from the current price of $7.559, with an average analyst price target of $5.3700, representing a -28.96% decrease. * **Key Events/News:** * **July 23, 2025:** ASP Isotopes Inc. Announced Pricing of $60 Million Underwritten Registered Direct Offering. * **August 15, 2025:** ASP Isotopes Misses on Q2 Earnings. Reported revenue of $1.2 million, up 17% YOY, but fell short of Wall Street's $1.6 million forecast. Also reported ($1.03) EPS, missing consensus of ($0.11) by ($0.92). * **September 9, 2025:** CEO Paul Elliot Mann sold 81,077 shares, valued at $680,236.03. This is below the $5 million threshold, so it will not be included as an explanatory factor. * **October 13/14, 2025:** ASPI stock saw a 31% intraday rise on Oct. 13 after the company unveiled recent business updates, securing major supply deals, expanding production, and moving into radiopharmaceuticals. These updates caused the stock to reach a fresh 52-week high of $14.49 on Oct. 14. * **November 5, 2025:** ASP Isotopes' UK Subsidiary, Quantum Leap Energy Ltd., Enters Early Engagement Process with UK Nuclear Regulators. * **November 7, 2025:** Quantum Leap Energy LLC Announces Private Placement of Convertible Notes Led by American Ventures LLC. * **November 12, 2025:** ASP Isotopes Announces Quantum Leap Energy's Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering. This also suggests a spin-off. * **November 17, 2025:** ASP Isotopes to Provide Quarterly Business Update Call on November 21, 2025. * **November 18, 2025 (today):** ASPI is expected to announce Q3 2025 results before the market opens. Analysts expect ($0.10) EPS and $2.248M in revenue. To determine the -20.2% movement, I need the stock price on July 31, 2025, and today, November 18, 2025. From the Nasdaq historical data, I don't have July 31, 2025, directly. However, I have news from July 23, 2025, indicating a $60 million offering. Let's try to find an approximate price for July 31, 2025. Searching for "ASPI stock price July 31 2025" or "ASPI close price July 31 2025" in my next search. Let's assume the user's -20.2% is a fact I need to explain. I will use the available news and stock price points around the dates to frame the explanation. From the search results, I have a clear indication of a significant price high around October 13-14, 2025 ($14.49) and then a drop to around $8.11 on November 14, 2025, and $8.92 on November 10, 2025. The current price on November 18, 2025, is 8.11 USD according to TradingView for a specific moment, and Nasdaq historical quotes also show $8.11 on Nov 14, 2025. MarketBeat says ASPI stock opened at $8.92 on November 11 (Tuesday). I need to confirm the price around July 31, 2025 to calculate the -20.2%. Nasdaq historical data snippet starts from November 7, 2025. Another snippet from Quiver Quantitative on July 23, 2025 mentions "ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering." And on July 17, 2025: "$ASPI stock is up 7% today. Here's what we see in our data." This does not give a specific price. Let's try to find a closing price for July 31, 2025, or an approximate value. If I can't find the exact price for July 31, 2025, I will have to work with the information available and acknowledge the stock's volatility and the events that would contribute to a decline from a higher point. Given the October 13, 2025 high of $14.49 and the price of around $8.11-$8.92 in mid-November, a significant drop has occurred. The "month change is a -38.93% fall" as of November 18, 2025, suggests a recent steep decline. Let's assume the user's premise of a -20.2% drop from 7/31/2025 to 11/18/2025 is correct. I will focus on finding the *reasons* for a decline within that period. Key events causing downward pressure: 1. **Q2 2025 Earnings Miss (August 15, 2025):** The company reported ($1.03) EPS, significantly missing analyst estimates of ($0.11), and revenue of $1.2 million, below the $1.6 million forecast. This clearly signals underperformance and would likely lead to a stock price drop. 2. **Dilution from $60 Million Offering (July 23, 2025):** While providing capital, a direct offering can cause dilution for existing shareholders, putting downward pressure on the stock price. 3. **Uncertainty and Speculative Nature:** The company is described as "pre-commercial stage" and "development stage", with its business still "speculative". Despite positive developments, the inherent risk and lack of consistent profitability can lead to volatility and declines, especially after a run-up. 4. **Cash Burn and Need for Capital:** An article on November 17, 2025, mentions needing to "get updated financials to know the current cash balance and if additional cash burn is incurred with the launch of enrichment." This indicates ongoing concerns about the company's financial health and need for capital, which can negatively impact investor sentiment. 5. **Analyst Outlook:** While some analysts have a "Strong Buy" rating, the StockScan forecast for the next 30 days from November 18, 2025, is "generally negative," with an average price target representing a -28.96% decrease from the current price. This bearish sentiment, particularly after a period of growth, could contribute to a decline. I have 5 points now. I need to make sure I don't include insider selling unless it exceeds $5 million. The CEO's sale was $680,236.03, so it does not meet the criteria. Now I need to structure the response with HTML formatting. I will assume the -20.2% figure as given and explain potential reasons. I need to make sure I cite correctly at the end of each sentence that refers to a search result.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
ASPI Return---13%153%60%358%
Peers Return11%18%-6%27%38%-12%90%
S&P 500 Return16%27%-19%24%23%13%107%

Monthly Win Rates [3]
ASPI Win Rate--0%50%50%70% 
Peers Win Rate52%40%40%52%50%48% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
ASPI Max Drawdown----80%-7%-13% 
Peers Max Drawdown-44%-9%-18%-21%-19%-36% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: MEOH, DOW, HWKN, HUN, ASPI.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 11/17/2025 (YTD)

How Low Can It Go

Unique KeyEventASPIS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-88.6%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven775.0%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven260 days464 days

Compare to MEOH, DOW, HWKN, HUN, ASPI


In The Past

ASP Isotopes's stock fell -88.6% during the 2022 Inflation Shock from a high on 11/11/2022. A -88.6% loss requires a 775.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About ASP Isotopes (ASPI)

Better Bets than ASP Isotopes (ASPI)

Latest Trefis Analyses

Title
0ARTICLES

Trade Ideas

Select past ideas related to ASPI. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ATR_10312025_Dip_Buyer_ValueBuy10312025ATRAptarGroupDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
2.2%2.2%-2.5%
SLGN_10312025_Dip_Buyer_ValueBuy10312025SLGNSilganDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-1.6%-1.6%-1.6%
TGLS_10242025_Dip_Buyer_ValueBuy10242025TGLSTecnoglassDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-25.1%-25.1%-25.2%
NEM_10242025_Quality_Momentum_RoomToRun_10%10242025NEMNewmontQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
5.3%5.3%-5.7%
RGLD_10242025_Quality_Momentum_RoomToRun_10%10242025RGLDRoyal GoldQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
1.8%1.8%-7.3%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ATR_10312025_Dip_Buyer_ValueBuy10312025ATRAptarGroupDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
2.2%2.2%-2.5%
SLGN_10312025_Dip_Buyer_ValueBuy10312025SLGNSilganDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-1.6%-1.6%-1.6%
TGLS_10242025_Dip_Buyer_ValueBuy10242025TGLSTecnoglassDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-25.1%-25.1%-25.2%
NEM_10242025_Quality_Momentum_RoomToRun_10%10242025NEMNewmontQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
5.3%5.3%-5.7%
RGLD_10242025_Quality_Momentum_RoomToRun_10%10242025RGLDRoyal GoldQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
1.8%1.8%-7.3%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for ASP Isotopes

Financials

ASPIMEOHDOWHWKNHUNMedian
NameASP Isot.Methanex Dow Hawkins Huntsman  
Mkt Price7.2435.7121.67126.558.2421.67
Mkt Cap0.52.815.42.61.42.6
Rev LTM53,56940,9131,0455,7803,569
Op Inc LTM-33516472121-24121
FCF LTM-31928-1,1207919979
FCF 3Y Avg-1851590389126126
CFO LTM-201,0571,562123366366
CFO 3Y Avg-128033,645133332332

Growth & Margins

ASPIMEOHDOWHWKNHUNMedian
NameASP Isot.Methanex Dow Hawkins Huntsman  
Rev Chg LTM99.6%-3.4%-5.3%11.9%-3.5%-3.4%
Rev Chg 3Y Avg--7.7%-11.3%5.3%-11.5%-9.5%
Rev Chg Q17.2%-0.8%-8.3%13.5%-5.2%-0.8%
QoQ Delta Rev Chg LTM4.0%-0.2%-2.2%3.3%-1.4%-0.2%
Op Mgn LTM-720.3%14.4%1.2%11.6%-0.4%1.2%
Op Mgn 3Y Avg-9.5%3.5%11.4%1.2%6.5%
QoQ Delta Op Mgn LTM-73.6%0.8%-0.5%-0.4%-0.5%-0.5%
CFO/Rev LTM-429.4%29.6%3.8%11.8%6.3%6.3%
CFO/Rev 3Y Avg-21.9%8.3%13.8%5.5%11.0%
FCF/Rev LTM-682.8%26.0%-2.7%7.5%3.4%3.4%
FCF/Rev 3Y Avg-14.2%1.9%9.2%2.1%5.7%

Valuation

ASPIMEOHDOWHWKNHUNMedian
NameASP Isot.Methanex Dow Hawkins Huntsman  
Mkt Cap0.52.815.42.61.42.6
P/S115.40.80.42.50.20.8
P/EBIT-5.35.1130.721.4-11.85.1
P/E-5.312.9-13.631.6-4.3-4.3
P/CFO-26.92.69.921.43.93.9
Total Yield-18.9%9.6%3.9%3.6%-10.8%3.6%
Dividend Yield0.0%1.9%11.2%0.4%12.3%1.9%
FCF Yield 3Y Avg-20.4%17.3%1.2%4.6%5.7%4.6%
D/E0.21.31.30.11.71.3
Net D/E0.11.21.00.11.41.0

Returns

ASPIMEOHDOWHWKNHUNMedian
NameASP Isot.Methanex Dow Hawkins Huntsman  
1M Rtn-27.7%5.1%-1.0%-21.6%0.2%-1.0%
3M Rtn-22.1%5.6%-5.4%-27.0%-16.1%-16.1%
6M Rtn-3.7%7.2%-25.2%1.0%-30.6%-3.7%
12M Rtn-0.4%-14.7%-47.1%3.0%-54.7%-14.7%
3Y Rtn186.2%-2.1%-48.3%207.4%-65.1%-2.1%
1M Excs Rtn-27.8%4.9%-1.1%-21.8%0.1%-1.1%
3M Excs Rtn-22.5%2.1%-10.6%-29.9%-21.4%-21.4%
6M Excs Rtn-15.6%-4.7%-37.1%-10.9%-42.5%-15.6%
12M Excs Rtn-24.6%-25.4%-59.7%-9.7%-66.4%-25.4%
3Y Excs Rtn102.5%-71.6%-116.8%132.7%-134.2%-71.6%

Financials

Price Behavior

Short Interest

Short Interest: As Of Date10312025
Short Interest: Shares Quantity17,543,519
Short Interest: % Change Since 1015202510.9%
Average Daily Volume8,962,575
Days-to-Cover Short Interest1.96
Basic Shares Quantity73,009,938
Short % of Basic Shares24.0%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025814202510-Q 6/30/2025
3312025520202510-Q 3/31/2025
12312024331202510-K 12/31/2024
93020241119202410-Q 9/30/2024
6302024819202410-Q 6/30/2024
3312024515202410-Q 3/31/2024
12312023410202410-K 12/31/2023
93020231114202310-Q 9/30/2023
6302023814202310-Q 6/30/2023
3312023519202310-Q 3/31/2023
12312022331202310-K 12/31/2022
93020221222202210-Q 9/30/2022
630202211142022424B4 6/30/2022

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value
Value of
Held Shares
Form
0Ainscow RobertInterim CEO and COO2212030Sell13.6022,500305,97822,400,178Form